1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
2
|
Graff JM: Embryonic patterning: To BMP or
not to BMP, that is the question. Cell. 89:171–174. 1997.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Wozney JM and Rosen V: Bone morphogenetic
protein and bone morphogenetic protein gene family in bone
formation and repair. Clin Orthop Relat Res. 346:26–37. 1998.
View Article : Google Scholar
|
4
|
Urist MR: Bone: Formation by
autoinduction. Science. 150:893–899. 1965. View Article : Google Scholar : PubMed/NCBI
|
5
|
Wozney JM, Rosen V, Celeste AJ, Mitsock
LM, Whitters MJ, Kriz RW, Hewick RM and Wang EA: Novel regulators
of bone formation: Molecular clones and activities. Science.
242:1528–1534. 1988. View Article : Google Scholar : PubMed/NCBI
|
6
|
Boon MR, van der Horst G, van der Pluijm
G, Tamsma JT, Smit JW and Rensen PC: Bone morphogenetic protein 7:
A broad-spectrum growth factor with multiple target therapeutic
potency. Cytokine Growth Factor Rev. 22:221–229. 2011. View Article : Google Scholar : PubMed/NCBI
|
7
|
Buijs JT, Henriquez NV, van Overveld PG,
van der Horst G, Que I, Schwaninger R, Rentsch C, Ten Dijke P,
Cleton-Jansen AM, Driouch K, et al: Bone morphogenetic protein 7 in
the development and treatment of bone metastases from breast
cancer. Cancer Res. 67:8742–8751. 2007. View Article : Google Scholar : PubMed/NCBI
|
8
|
Buijs JT, Rentsch CA, van der Horst G, van
Overveld PG, Wetterwald A, Schwaninger R, Henriquez NV, Ten Dijke
P, Borovecki F, Markwalder R, et al: BMP7, a putative regulator of
epithelial homeostasis in the human prostate, is a potent inhibitor
of prostate cancer bone metastasis in vivo. Am J Pathol.
171:1047–1057. 2007. View Article : Google Scholar : PubMed/NCBI
|
9
|
Botchkarev VA: Bone morphogenetic proteins
and their antagonists in skin and hair follicle biology. J Invest
Dermatol. 120:36–47. 2003. View Article : Google Scholar : PubMed/NCBI
|
10
|
Miyazono K, Maeda S and Imamura T: BMP
receptor signaling: Transcriptional targets, regulation of signals,
and signaling cross-talk. Cytokine Growth Factor Rev. 16:251–263.
2005. View Article : Google Scholar : PubMed/NCBI
|
11
|
Kawabata M, Imamura T and Miyazono K:
Signal transduction by bone morphogenetic proteins. Cytokine Growth
Factor Rev. 9:49–61. 1998. View Article : Google Scholar : PubMed/NCBI
|
12
|
Massagué J, Seoane J and Wotton D: Smad
transcription factors. Genes Dev. 19:2783–2810. 2005. View Article : Google Scholar : PubMed/NCBI
|
13
|
Derynck R and Zhang YE: Smad-dependent and
Smad-independent pathways in TGF-beta family signalling. Nature.
425:577–584. 2003. View Article : Google Scholar : PubMed/NCBI
|
14
|
ten Dijke P, Korchynskyi O,
Valdimarsdottir G and Goumans MJ: Controlling cell fate by bone
morphogenetic protein receptors. Mol Cell Endocrinol. 211:105–113.
2003. View Article : Google Scholar : PubMed/NCBI
|
15
|
Onichtchouk D, Chen YG, Dosch R, Gawantka
V, Delius H, Massagué J and Niehrs C: Silencing of TGF-beta
signalling by the pseudoreceptor BAMBI. Nature. 401:480–485. 1999.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Groppe J, Greenwald J, Wiater E,
Rodriguez-Leon J, Economides AN, Kwiatkowski W, Affolter M, Vale
WW, Izpisua Belmonte JC and Choe S: Structural basis of BMP
signalling inhibition by the cystine knot protein Noggin. Nature.
420:636–642. 2002. View Article : Google Scholar : PubMed/NCBI
|
17
|
Hsu DR, Economides AN, Wang X, Eimon PM
and Harland RM: The Xenopus dorsalizing factor Gremlin identifies a
novel family of secreted proteins that antagonize BMP activities.
Mol Cell. 1:673–683. 1998. View Article : Google Scholar : PubMed/NCBI
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
19
|
Na YR, Seok SH, Kim DJ, Han JH, Kim TH,
Jung H, Lee BH and Park JH: Bone morphogenetic protein 7 induces
mesenchymal-to-epithelial transition in melanoma cells, leading to
inhibition of metastasis. Cancer Sci. 100:2218–2225. 2009.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Hsu MY, Rovinsky SA, Lai CY, Qasem S, Liu
X, How J, Engelhardt JF and Murphy GF: Aggressive melanoma cells
escape from BMP7-mediated autocrine growth inhibition through
coordinated Noggin upregulation. Lab Invest. 88:842–855. 2008.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Klose A, Waerzeggers Y, Monfared P,
Vukicevic S, Kaijzel EL, Winkeler A, Wickenhauser C, Löwik CW and
Jacobs AH: Imaging bone morphogenetic protein 7 induced cell cycle
arrest in experimental gliomas. Neoplasia. 13:276–285. 2011.
View Article : Google Scholar : PubMed/NCBI
|
22
|
González-Gómez P, Crecente-Campo J,
Zahonero C, de la Fuente M, Hernández-Laín A, Mira H, Sánchez-Gómez
P and Garcia-Fuentes M: Controlled release microspheres loaded with
BMP7 suppress primary tumors from human glioblastoma. Oncotarget.
6:10950–10963. 2015. View Article : Google Scholar : PubMed/NCBI
|
23
|
Sakai H, Furihata M, Matsuda C, Takahashi
M, Miyazaki H, Konakahara T, Imamura T and Okada T: Augmented
autocrine bone morphogenic protein (BMP) 7 signaling increases the
metastatic potential of mouse breast cancer cells. Clin Exp
Metastasis. 29:327–338. 2012. View Article : Google Scholar : PubMed/NCBI
|
24
|
Hu M, Cui F, Liu F, Wang J, Wei X and Li
Y: BMP signaling pathways affect differently migration and invasion
of esophageal squamous cancer cells. Int J Oncol. 50:193–202. 2017.
View Article : Google Scholar
|
25
|
Zhang T, Fu J, Li Y, Wang Y, Zhang L and
Liu Y: Bone morphogenetic protein 7 is associated with the nodal
invasion of colon cancer. Oncol Lett. 11:1707–1712. 2016.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Tu WH, Thomas TZ, Masumori N, Bhowmick NA,
Gorska AE, Shyr Y, Kasper S, Case T, Roberts RL, Shappell SB, et
al: The loss of TGF-beta signaling promotes prostate cancer
metastasis. Neoplasia. 5:267–277. 2003. View Article : Google Scholar : PubMed/NCBI
|
27
|
Yang S, Zhong C, Frenkel B, Reddi AH and
Roy-Burman P: Diverse biological effect and Smad signaling of bone
morphogenetic protein 7 in prostate tumor cells. Cancer Res.
65:5769–5777. 2005. View Article : Google Scholar : PubMed/NCBI
|
28
|
Yang S, Lim M, Pham LK, Kendall SE, Reddi
AH, Altieri DC and Roy-Burman P: Bone morphogenetic protein 7
protects prostate cancer cells from stress-induced apoptosis via
both Smad and c-Jun NH2-terminal kinase pathways. Cancer Res.
66:4285–4290. 2006. View Article : Google Scholar : PubMed/NCBI
|
29
|
Bokobza SM, Ye L, Kynaston HE, Mansel RE
and Jiang WG: Reduced expression of BMPR-IB correlates with poor
prognosis and increased proliferation of breast cancer cells.
Cancer Genomics Proteomics. 6:101–108. 2009.PubMed/NCBI
|
30
|
Ye L, Lewis-Russell JM, Kynaston H and
Jiang WG: Endogenous bone morphogenetic protein-7 controls the
motility of prostate cancer cells through regulation of bone
morphogenetic protein antagonists. J Urol. 178:1086–1091. 2007.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Ying X, Sun Y and He P: MicroRNA-137
inhibits BMP7 to enhance the epithelial-mesenchymal transition of
breast cancer cells. Oncotarget. 8:18348–18358. 2017. View Article : Google Scholar : PubMed/NCBI
|
32
|
Yin Y, Yang Y, Yang L, Yang Y, Li C, Liu X
and Qu Y: Overexpression of Gremlin promotes non-small cell lung
cancer progression. Tumour Biol. 37:2597–2602. 2016. View Article : Google Scholar
|
33
|
Li X, Chen T, Shi Q, Li J, Cai S, Zhou P,
Zhong Y and Yao L: Angiopoietin-like 4 enhances metastasis and
inhibits apoptosis via inducing bone morphogenetic protein 7 in
colorectal cancer cells. Biochem Biophys Res Commun. 467:128–134.
2015. View Article : Google Scholar : PubMed/NCBI
|
34
|
Megumi K, Ishigami S, Uchikado Y, Kita Y,
Okumura H, Matsumoto M, Uenosono Y, Arigami T, Kijima Y, Kitazono
M, et al: Clinicopathological significance of BMP7 expression in
esophageal squamous cell carcinoma. Ann Surg Oncol. 19:2066–2071.
2012. View Article : Google Scholar :
|
35
|
Aoki M, Ishigami S, Uenosono Y, Arigami T,
Uchikado Y, Kita Y, Kurahara H, Matsumoto M, Ueno S and Natsugoe S:
Expression of BMP-7 in human gastric cancer and its clinical
significance. Br J Cancer. 104:714–718. 2011. View Article : Google Scholar : PubMed/NCBI
|
36
|
Xu G, Tang S, Yang J, Chen K, Kang J, Zhao
G, Feng F, Yang X, Zhao L, Lu Q, et al: BMP7 expression in
esophageal squamous cell carcinoma and its potential role in
modulating metastasis. Dig Dis Sci. 58:1871–1879. 2013. View Article : Google Scholar : PubMed/NCBI
|
37
|
Kwak C, Park YH, Kim IY, Moon KC and Ku
JH: Expression of bone morphogenetic proteins, the subfamily of the
transforming growth factor-beta superfamily, in renal cell
carcinoma. J Urol. 178:1062–1067. 2007. View Article : Google Scholar : PubMed/NCBI
|